powered by LeadingAge New York

FDA Guidance

May 10, 2022

FDA Guidance

FDA Limits Use of J&J Vaccine

Limitation is due to the J&J vaccine's link to rare but serious blood clots; mRNA vaccines are recommended instead.

Read More
Tags: COVID-19
February 8, 2022

FDA Guidance

Moderna’s COVID-19 Vaccine for 18+ Officially Approved by FDA and CDC

The vaccine is no longer under Emergency Use Authorization for 18+.

Read More
Tags: COVID-19
October 19, 2021

FDA Guidance

Additional Vaccine Boosters Moving Through Authorization Process

FDA also in early stages of reviewing oral antiviral treatments for COVID-19.

Read More
September 21, 2021

FDA Guidance

Pfizer Vaccine Boosters Expected Soon; Updated Vaccine Wastage Guidance Issued

Boosters recommended for those age 65+, health care workers, and those at high risk for COVID-19.

Read More
July 19, 2021

FDA Guidance

FDA Announces Revisions to EUA Fact Sheets for Janssen/Johnson & Johnson Vaccine

Fact sheets now include information regarding an observed increased risk of Guillain-Barré syndrome.

Read More